Krebs Biochemicals & Industries has informed that the meeting of Board of Directors of the Company is scheduled to be held on December 07, 2016, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2016. Further, in connection to the above, the trading window for dealing in shares of the Company will remain closed for the specified persons as defined in the Code from December 01, 2016 and shall reopen 48 hours after the publication of the results to the public.
The above information is a part of company’s filings submitted to BSE.
